Mk3475
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
2810 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 81 | 105 | 42 | 1 | 1 | 193 |
| Melanoma | D008545 | — | — | 58 | 81 | 13 | 1 | 5 | 119 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 32 | 59 | 9 | 1 | — | 82 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 143 | 91 | 1 | — | 2 | 182 |
| Carcinoma | D002277 | — | C80.0 | 48 | 83 | 15 | — | — | 123 |
| Lung neoplasms | D008175 | — | C34.90 | 45 | 61 | 7 | — | — | 92 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 35 | 66 | 5 | — | — | 88 |
| Colorectal neoplasms | D015179 | — | — | 39 | 45 | 5 | — | — | 69 |
| Triple negative breast neoplasms | D064726 | — | — | 25 | 48 | 8 | — | — | 68 |
| Squamous cell carcinoma | D002294 | — | — | 16 | 41 | 9 | — | — | 56 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | 34 | 32 | 7 | — | — | 55 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 22 | 40 | 3 | — | — | 49 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 28 | 29 | 2 | — | — | 45 |
Show 34 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 21 | 27 | — | — | — | 39 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 22 | 21 | — | — | — | 35 |
| Sarcoma | D012509 | — | — | 10 | 20 | — | — | — | 23 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 7 | 14 | — | — | — | 17 |
| Castration-resistant prostatic neoplasms | D064129 | — | — | 5 | 11 | — | — | — | 15 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 6 | 10 | — | — | — | 15 |
| B-cell lymphoma | D016393 | — | — | 6 | 9 | — | — | — | 13 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 8 | 8 | — | — | — | 11 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 4 | 6 | — | — | — | 9 |
| T-cell lymphoma | D016399 | — | — | 3 | 8 | — | — | — | 9 |
Show 139 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 2 | — | — | — | — | 2 |
| Myelodysplastic syndromes | D009190 | — | D46 | 2 | — | — | — | — | 2 |
| Lymphoid leukemia | D007945 | — | C91 | 2 | — | — | — | — | 2 |
| Thoracic neoplasms | D013899 | — | — | 2 | — | — | — | — | 2 |
| Neurologic manifestations | D009461 | — | — | 1 | — | — | — | — | 1 |
| Papillomaviridae | D027383 | — | — | 1 | — | — | — | — | 1 |
| Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
| Soft tissue neoplasms | D012983 | — | — | 1 | — | — | — | — | 1 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 1 | — | — | — | — | 1 |
| Respiratory tract neoplasms | D012142 | EFO_0003853 | D14 | 1 | — | — | — | — | 1 |
Show 9 more
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use